Advances in cell and molecular biology have engendered a wide range of techniques that can be used to study the molecular events that underlie the cause of disease, thus producing a new field of study called "molecular pathology." These techniques can be either slide-based or non-slide-based (solution-based). The slide-based techniques include immunohistochemistry, in situ hybridization, and in situ polymerase chain reaction; pathologists play a unique role in the administration of these techniques because of their ability to interpret the end product (i.e., the slide). In this manuscript, we briefly discussed the use and impact of these slide-based techniques within all phases of drug development in the pharmaceutical industry.
Center for Biologics Evaluation and Research (1997). Points to Consider in the Manufacture and Testing of monoclonal Antibody Products for Human Use. Docket No. 940-0259, USA Department of Health and Human Services . Food and Drug Administration.
2.
Erickson SL. O'Shea KS. Ghaboosi N., Loverro L.Frantz G.Bauer M.Lu LH and Moore MW (1997). ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2 and heregulin-deficient mice. Development124(24): 4999-5011.
3.
Shyjan AW, deSauvage FJ, Gillett NA, Goeddel DV, and Lowed DG (1992). Retinal guanylyl cyclase: A photoreceptor specific membrane guanylyl cyclase. Neuron9: 727-737.
4.
(1973). Stedman's Medical Dictionary. AG Cutler (managing ed.) Williams and Wilkins, Baltimore.
5.
Warren RS. Yuan H., Matli MR, Gillett NA, and Ferrara N. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest.95: 1789-1797.
6.
Farkas DH, Kaul KL, Wiedbrauk DL, and Kiechle FL (1996). Specimen collection and storage for diagnostic molecular pathology investigation. Arch. Pathol. Lab. Med.120: 591-596.
7.
Figueroa ME and Rasheed S. (1991). Molecular pathology and diagnosis of infectious diseases. Am. J. Clin. Pathol.95(suppl 1): S8-S21.
8.
Kappel CA, Bierberich CJ, and Jay G. (1994). Evolving concepts in molecular pathology. FASEB8,9: 583-592.
9.
Kuper CF, Schuurman HJ, and Vox JG (1995). Pathology in immunotoxicology. Methods Immunotoxicol. 1: 397-436.
10.
Alegre ML, Peterson LJ, Xu D., Satter HA, Jeyarafah DR, Kowalkowski K., Thistlethwaite JR, Zivin HA, Jolliffe L., and Bluestone J. (1994). A nonactivating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation57: 1537-1543.
11.
Anderson LM, Ward JL, Anderson M., Ward JM, Park SS, Jones AB, Junker JL, Belboin HV, and Rice JM (1987). Immunohistochemical determination of inducibility phenotype with a monoclonal antibody to a methylcholanthrene-inducible isozyme of cytochrome P-450. Cancer Res.47: 6079-6085.
12.
Barclay AN, Birkeland ML, Brown MH, Beyers AD, Davis SJ, Samoza C., and Williams AF (1993). The Leukocyte Antigen Facts Book. Academic Press, Inc., San Diego.
13.
Brandtzeg P. (1982). Tissue preparation methods for immunocytochemistry . In: Techniques in Immunocytochemistry , CR Bullock and Petrausz, eds., Academic Press, New York, p. 1.
14.
Burt AD, Robertson JL, Heir J., and MacSween Rnm (1986). Desmin-containing stellate cells in rat liver: Distribution in normal animals and response to experimental acute liver injury . J. Pathol.150: 29-35.
15.
Cattoretti G. , Pileri S., Parraviccini C., Becker Mhb, Poggi S., Bifulco C., Key G., D'amato L., Sabattini E., Feudale E., Reynolds F., Gerdes J., and Rilke F. (1993). Antigen unmasking on formalin-fixed, paraffin embedded tissue sections. J. Pathol.171: 83-98.
16.
Connolly KM and Bogdanffy MS (1993). Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: A dual-stain comparison with 5-bromo-2'-deoxyuridine. J. Histochem. Cytochem.41: 1-6.
17.
Ferran C., Sheehan K., Dy M., Schrieber R., Merite S., Landais P., Noel LH, Grau G., Bluestone J., Bach JF, and Chatenoud L. (1990). Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation. Eur. J. Immunol.20: 509-515.
18.
Hall WC and Rojko JL (1996). The use of immunohistochemistry for evaluating the liver. Toxicol. Pathol.24(1): 4-12.
19.
Hsu S., Raine L., and Fanger H. (1981). Use of avidin-biotin-peroxidase complexes (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem.29: 577-580.
20.
Keshgegian AA and Cnaan A. (1995). Proliferation markers in breast carcinoma. Am. J. Clin. Pathol.104: 42-49.
21.
Lasky LA (1992). Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science258: 964-969.
22.
Levine AJ, Momand J., and Finlay C. (1991). The p53 tumor suppressor gene. Nature351: 453.
23.
Munro JM (1993). Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur. Heart J.14(suppl K): 72.
24.
Murray GI and Burke MD (1995). Immunohistochemistry of drug-metabolizing enzymes . Biochem. Pharmacol.50: 895.
25.
Quarles RH, Ilyas AA, and Willison HJ (1986). Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chem. Phys. Lipids42: 23.
26.
Revillard JP , Robinet E., Goldman M., Bazin H., Latinne D., and Chatenoud L. (1995). In vitro correlates of the acute toxic syndrome induced by some monoclonal antibodies: A rationale for the design of predictive tests. Toxicology96: 51.
27.
Ruizeveld de Winter JA, Trapman JA, Vermey M., Mulder E., Zegers ND, and Van der Kwast TH (1991). Androgen receptor expression in human tissues: An immunohistochemical study . J. Histochem. Cytochem.39: 927.
28.
Shi SR, Gu J., Kalra KL, Chen T., Cote RJ, and Taylor CR (1995). Antigen retrieval technique: A novel approach to immunohistochemistry on routinely processed tissue sections. CellVision2: 6.
29.
Springer TA (1990). Adhesion receptors of the immune system. Nature346: 425.
30.
Stamatoglou SC, Enrich C., Manson MM, and Hughes RC (1992). Temporal changes in the expression and distribution of adhesion molecules during liver development and regeneration. J. Cell Biol.116: 1507.
31.
Stamp Gwh (1989). Evaluation of immunohistochemistry in tumor diagnosis . J. Histotechnol. 12: 323.
32.
Taylor CR (1978). Immunoperoxidase techniques. Practical and theoretical aspects. Arch. Pathol. Lab. Med.102: 113.
33.
Trukhanova LS, Hong Hhl, Sills RC, Bowser AD, Gaul B., Boor-man GA, Turusov VS, Devereux RH, and Dixon D. (1998). Predominant p53 G→A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethlhydrazine. Toxicol. Pathol.26(3): 367374.
34.
Yu CC, Woods AL, and Levison D. (1992). The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem. J.24: 121.
35.
Barnes JL (1998). In situ hybridization in the study of remodeling in proliferative glomerulonephritis. Toxicol. Pathol.26(1): 43-51.
36.
Biffo S. (1992). In situ hybridization: Optimization of the techniques for collecting and fixing the specimens. Liver12: 227.
37.
Biffo S. and Tolosano E. (1992). The use of radioactively labelled riboprobes for in situ hybridization: Background and examples of application. Liver12: 230.
38.
Brown C. (1998). In situ hybridization with riboprobes: An overview for veterinary pathologists. Vet. Pathol.35: 159-167.
39.
Chan F., Yeger H., Pawlin G., and Becker LE (1994). In situ hybridization of mRNA with biotin and digoxigenin labeled probes. J. Histotechnol. 17: 307.
40.
DeLellis RA (1994). In situ hybridization techniques for the analysis of gene expression: Applications in tumor pathology. Hum. Pathol.25: 580.
41.
Emson PC (1993). In-situ hybridization as a methodological tool for the neuroscientist. TINS16: 9.
42.
Gowans EJ (1992). Autoradiographic detection of radiolabelled probes by in situ hybridization. Liver12: 238.
43.
Holm R., Karlsen F., and Nesland JM (1992). In situ hybridization with nonisotopic probes using different detection systems. Modern Pathol. 5: 315.
44.
Lewis ME, Sherman TG, and Watson SJ (1985). In situ hybridization histochemistry with synthetic oligonucleotides: Strategies and methods. Peptides6: 75.
45.
Lu LH and Gillett NA (1994). An optimized protocol for in situ hybridization using PCR-generated 33-P-labeled riboprobes. CellVision1: 169-176.
46.
Malarkey DE and Maronpot RR (1996). Polymerase chain reaction and in situ hybridization: Applications in toxicological pathology . Toxicol. Pathol.24(1):13—24.
47.
Moorman AF, De Boer PA, Vermeulen JL, and Lamers WH (1993). Practical aspects of radio-isotopic in situ hybridization on RNA. Histochem. J.25: 251.
48.
Pacchioni D. , Papotti M., Bonino F., Bussolati G., and Negro F. (1992). Detection of cytomegalovirus by in situ hybridization using a digoxigenin-tailed oligonucleotide. Liver12: 257.
49.
Singer RH, Lawrence JB, and Villnave C. (1986). Optimization of in situ hybridization using isotopic and non-isotopic detection methods. Biotechniques4: 230.
50.
Stoler MH (1993). In situ hybridization: A research technique or routine diagnostic test?Arch. Pathol. Lab. Med.117: 478.
51.
Trabandt A. , Gay RE, Sukhatme VP, and Gay S. (1995). Enzymatic detection systems for non-isotopic in situ hybridization using biotinylated cDNA probes. Histochem. J.27: 280.
52.
Viale G. and Dell'Orto P. (1992). Non-radioactive nucleic acid probes: Labelling and detection procedures. Liver12: 243.
53.
Ertsey R. and Scavo LM (1998). Coverslip mounter-immersion cycled in situ RT-PCR for the localization of mRNA in tissue sections. Biotechniques24: 92-100.
54.
Heniford BW, Siu-Shum A., Leonberger M., and Hendler FJ (1993). Variation in cellular EGF receptor mRNA expression demonstrated by in situ reverse transcriptase polymerase chain reaction. Nucleic Acids Res.21: 3159.
55.
Komminoth P. and Long AA (1993). In-situ polymerase chain reaction: An overview of methods, applications and limitations of a new molecular technique. Virch. Arch. B Cell Pathol. 64: 67.
56.
Long AA, Komminoth P., and Wolfe H. (1993). Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections: Detection of viral DNA, gene rearrangements and chromosomal translocations. Histochemistry99: 151.
57.
Nuovo GJ, Gallery J., Horn R., MacConnell P., and Bloch W. (1993). Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Meth. Appl. 2: 305.
58.
Nuovo GJ, MacConnell P., Forde A., and Delvenne P. (1991). Detection of human papillomavirus DNA in formalin fixed tissues by in situ hybridization after amplification by PCR. Am. J. Pathol.189: 847.
59.
Patel VG, Siu-Shum A., Heniford BW, Wieman TJ, and Hendler FJ (1994). Detection of epidermal growth factor receptor mRNA in tissue sections from biopsy specimens using in situ polymerase chain reaction. Am. J. Pathol.144: 7.
60.
Ray R., Komminoth P., Machado M., and Wolfe HJ (1991). Combined polymerase chain reaction and in-situ hybridization for the detection of single copy genes and viral genomic sequences in intact cells. Modern Pathol. 19: 242.
61.
Spann W., Pachmann K., Zabnieuska H., Pielmeier A., and Emmerich B. (1991). In situ amplification of single copy gene segments in individual cells by the polymerase chain reaction. Infection19: 242.
62.
Walboomers Jmm, Melchers Wjg, Mullink H., Meijer Cjlm, Struyk A., Quint Wgj, van der Noordaa J., and ter Schegget J. (1988). Sensitivity of in situ detection with biotinylated probes of human papillomavirus type 16 DNA in frozen tissue sections of squamous cell carcinoma of the cervix . Am. J. Pathol.139: 587.
